Mergers and Aquisitions Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy
Conditions: Recurrent B Acute Lymphoblastic Leukemia; Recurrent B-Cell Non-Hodgkin Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B-Cell Non-Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma Interventions: Biological: Interferon Beta-1A; Procedure: X-Ray Imaging; Procedure: Echocardiography; Procedure: Multigated Acquisition Scan; Procedure: Computed Tomography; Procedure: Positron Emission Tomography; Procedure: Lumbar Puncture; Procedure: Bone Marrow Aspira tion; Procedure: Bone Marrow Bi...
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
